How China Is Rewriting the Rules Global Drug Development

In part two of our conversation, Lingshi Tan explores how China’s integrated biopharma ecosystem is reshaping assumptions about speed, cost, innovation, and cross-border clinical development

By
James Strachan
August 5, 2026
16 min

The Medicine Maker

Original Source(s)

The Medicine Maker

How China Is Rewriting the Rules Global Drug Development

by James Strachan
August 5, 2026

Related Content

The Ophthalmologist

The Emotional Side of Cataracts

Study investigates how emotions might influence senile cataract care outcomes

August 4, 2026
3 min

Emergency Medicine Journal

Staff perspectives on implementing opt-out blood-borne virus testing in English emergency departments: a qualitative study

by Siobhán Allison, Tom May, Jonathan Roberts, Rachel Hill-Tout, Stephen Hindle, Matthew Hickman, Lucy Yardley, Rachel Todd, Robyn Heath, Jeremy Horwood
August 1, 2026

Gut

Secondary bile acid production by gut bacteria promotes Western diet-associated colorectal cancer

by Annika Osswald, Esther Wortmann, David Wylensek, Stephanie Kuhls, Olivia I Coleman, Kenneth Peuker, Anne Strigli, Quinten R Ducarmon, Martin Larralde, Wei Liang, Nicole S Treichel, Fabian Schumacher, Colin Volet, Silke Matysik, Karin Kleigrewe, Michael Gigl, Sascha Rohn, Chun-Jun Guo, Burkhard Kleuser, Gerhard Liebisch, Angelika Schnieke, Jason M Ridlon, Rizlan Bernier-Latmani, Georg Zeller, Sebastian Zeissig, Dirk Haller, Krzysztof Flisikowski, Thomas Clavel, Soeren Ocvirk
August 1, 2026